as on September 18, 2025 at 1:29 am IST
Day's Low
Day's High
3.90%
Downside
5.19%
Upside
52 Week's Low
52 Week's High
35.74%
Downside
231.17%
Upside
Check Macrogenics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$92.9M
EPS (TTM)
-1.71
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
2.21%
PE Ratio (TTM)
-1.6
Industry PE ratio
-3.9281873111782475
P/B Ratio
0PEG Ratio
0.01
EBITDA
-70.5M
Revenue (TTM)
165.5M
Profit Margin
-21.99%
Return On Equity TTM
1724470900.00%
Track how Macrogenics, Inc. P/E has moved over time to understand its valuation trends.
Macrogenics, Inc. in the last 5 years
Lowest (0.00x)
September 17, 2025
Industry (-3.93x)
September 17, 2025
Today (-1.60x)
September 17, 2025
Highest (0.00x)
September 17, 2025
Today’s Price to Earnings Ratio: -1.60x
Compare market cap, revenue, PE, and other key metrics of Macrogenics, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $92.9M | -95.29% | -1.6 | -21.99% | |
BUY | $60.5B | 252.04% | -505.15 | -12.96% | |
NA | $39.0B | NA | NA | -3.89% | |
BUY | $100.3B | 44.17% | 27.85 | 31.86% | |
BUY | $59.6B | 1.78% | 14.1 | 31.37% |
The Macrogenics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Macrogenics, Inc. investment value today
Current value as on today
₹50,296
Returns
Returns from Macrogenics, Inc. Stock
Dollar Returns*
₹4,598 (+4.6%)
Based on 18 analysts
88.89%
Buy
11.11%
Hold
0.00%
Sell
Based on 18 analysts, 88.89% of analysts recommend a 'BUY' rating for Macrogenics, Inc.. Average target price of $3.4
Get share price movements and forecasts by analysts on Macrogenics, Inc..
What analysts predicted
54.71%UPSIDE
Target Price
$3.4
Current Price
$1.54
Analyzed by
18 Analysts
Target
$3.40
Macrogenics, Inc. target price $3.4, a slight upside of 54.71% compared to current price of $1.54. According to 18 analysts rating.
Search interest for Macrogenics, Inc. Stock has increased by 180% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:180% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Revenue is up for the last 2 quarters, 13.19M → 22.24M (in $), with an average increase of 40.7% per quarter
Profit Spike
Netprofit is up for the last 2 quarters, -41.03M → -36.25M (in $), with an average increase of 13.2% per quarter
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.9% return, outperforming this stock by 124.4%
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 173.9%
Price Dip
In the last 7 days, MGNX stock has moved down by -10.9%
Organisation | Macrogenics, Inc. |
Headquarters | 9704 Medical Center Drive, Rockville, MD, United States, 20850 |
Industry | Health Technology |
CEO | Mr. Eric Blasius Risser |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Dr. Stephen L. Eck M.D., Ph.D. | Senior VP of Clinical Development & Chief Medical Officer |
Dr. Thomas M. Spitznagel Ph.D. | Senior Vice President of Technical Operations |
Mr. Jeffrey Stuart Peters J.D. | Senior VP, General Counsel & Corporate Compliance Officer |
Ms. Beth Smith | VP, Controller & Treasurer |
Mr. James Karrels | Senior VP, CFO & Corporate Secretary |
Mr. Eric Blasius Risser | CEO, President & Director |
Dr. Ezio Bonvini M.D. | Senior VP of Research & Chief Scientific Officer |
Mr. Steve Harig | Senior Vice President of Human Resources |
Mr. Harish Krishnaswamy | Senior Vice President of Business Development & Portfolio Planning |
Macrogenics, Inc. share price today is $1.54 as on at the close of the market. Macrogenics, Inc. share today touched a day high of $1.62 and a low of $1.48.
Macrogenics, Inc. share touched a 52 week high of $5.1 on and a 52 week low of $0.99 on . Macrogenics, Inc. stock price today i.e. is closed at $1.54,which is 69.80% down from its 52 week high and 55.61% up from its 52 week low.
Macrogenics, Inc. market capitalisation is $0.00T as on .
Indian investors can start investing in Macrogenics, Inc. (MGNX) shares with as little as ₹87.816 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Macrogenics, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Macrogenics, Inc. share’s latest price of $1.54 as on September 18, 2025 at 1:29 am IST, you will get 6.4935 shares of Macrogenics, Inc.. Learn more about
fractional shares .
Macrogenics, Inc. stock has given -95.29% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?